- Home
- A-Z Publications
- Current Pharmaceutical Design
- Previous Issues
- Volume 20, Issue 14, 2014
Current Pharmaceutical Design - Volume 20, Issue 14, 2014
Volume 20, Issue 14, 2014
-
-
Imaging Requirements for Personalized Medicine: The Oncologists Point of View
Authors: V. Kruse, S. V. Belle and V. CocquytWhile conventional chemotherapy regimens aim to be cytotoxic against proliferating cells, molecular targeted therapies are directed at specific cancer-associated pathways. To optimize cancer care, an early evaluation of treatment response is warranted for any tumor type - and for any treatment – by using conventional imaging modalities such as ultrasound, CT and MR, FDG-PET or specific radiotracer. FDG-PET is one of Read More
-
-
-
Development of Peptide and Protein Based Radiopharmaceuticals
Authors: Evelien Wynendaele, Nathalie Bracke, Sofie Stalmans and Bart De SpiegeleerRadiolabelled peptides and proteins have recently gained great interest as theranostics, due to their numerous and considerable advantages over small (organic) molecules. Developmental procedures of these radiolabelled biomolecules start with the radiolabelling process, greatly defined by the amino acid composition of the molecule and the radionuclide used. Depending on the radionuclide selection, radiolabelling starting Read More
-
-
-
Small Molecule PET-Radiopharmaceuticals
Authors: Philip H. Elsinga and Rudi A.J.O. DierckxThis review describes several aspects required for the development of small molecule PET-tracers. Design and selection criteria are important to consider before starting to develop novel PET-tracers. Principles and latest trends in 11C and 18F-radiochemistry are summarized. In addition an update of some new developments in regulatory aspects is supplied.
-
-
-
Radiolabeled Probes Targeting Tyrosine-Kinase Receptors For Personalized Medicine
Authors: Mohamed Altai, Anna Orlova and Vladimir TolmachevReceptor tyrosine kinases (RTK) are transmembrane receptors regulating cellular proliferation, differentiation, apoptosis, motility and recruitment of the vasculature. Aberrant expression and/or function of RTK have been detected in many malignant tumors and are considered to be a part of the transformed phenotype. The action of several classes of anti-cancer drugs is based on specific recognition of RTK. Monoclonal antib Read More
-
-
-
Radiolabeled Imaging Probes Targeting Angiogenesis for Personalized Medicine
Angiogenesis is essential for tumor growth and inhibiting angiogenesis has become an important therapeutic strategy in clinical oncology. Nonetheless, the mechanisms behind anti-angiogenic therapeutics as well as resistance to these drugs remain unclear. With a lack of validated genetic or molecular biomarkers for anti-angiogenic responsiveness, novel methods to identify responsive patients are required. Non-inv Read More
-
-
-
Radiolabelled Probes Targeting Tumor Hypoxia for Personalized Medicine
Authors: Gilles Mees, Mike Sathekge, Alex Maes and Christophe Van de WieleHypoxia is a characteristic feature of many solid tumors which has been described in a wide range of tumor types. Its presence impairs the effectiveness of common anti-cancer therapies and accordingly, tumor hypoxia has been associated with an aggressive tumor phenotype, poor response to radio- and chemotherapy, and worse prognosis. In order to predict outcome and identify patients with a worse prognosis an Read More
-
-
-
Molecular Imaging of Apoptosis for Early Prediction of Therapy Efficiency
Authors: Marijke De Saint-Hubert, Matthias Bauwens and Felix M. MottaghyEvasion of apoptosis is one of the hallmarks of cancer and any effective therapy primarily attempts to induce apoptosis. The evaluation of the degree of success of cancer therapy is currently mainly based on clinical and laboratory parameters and in a later stage on tumor shrinkage. However, none of these parameters provide an objective and early analysis of a therapeutic effect. Molecular imaging may provide a to Read More
-
-
-
Radiolabeled Probes Targeting G-Protein-Coupled Receptors for Personalized Medicine
More LessThe G-protein coupled receptor system is involved in a range of cell types and actions and as such has a universal potential in identifying cell functions. The most widely explored system is that of the somatostatin receptors which has been exploited for both imaging and therapy. However, even with this fairly simple system, variation is seen in the behaviour of cells between patients and within different cell population within Read More
-
-
-
Radiolabelled Probes Targeting Infection and Inflammation for Personalized Medicine
Authors: Alberto Signore, Chiara Lauri and Filippo GalliInflammatory and infectious diseases include many different clinical conditions not often well recognised and characterized with conventional radiology and biochemical tests. Radiological techniques (TC, MRI, US) show anatomical changes that usually occur in chronic stages of the disease leading to a delayed diagnosis and therapy. The possibility of Nuclear Medicine imaging to detect biological and biochemical changes in t Read More
-
-
-
microRNA as Biomarkers and Regulator of Cardiovascular Development and Disease
Authors: Shinji Hagiwara, Phillip Kantharidis and Mark E. CooperMicroRNAs are small noncoding RNAs that have emerged as important regulators of many biological and pathological processes, including those relevant to the development of the heart and cardiovascular disease. Several recent studies using genetic models and profiling of microRNAs have established the important role of these novel molecules in a number of conditions of the heart. These studies have led to a flurry of rese Read More
-
-
-
Novel Approach to Cardiovascular Diseases: A Promising Probability of (Pro)Renin Receptor [(P)RR]
Authors: Takashi Ando and Atsuhiro IchiharaInhibition of the renin-angiotensin system (RAS) has been shown to have beneficial effects in cardiovascular disease prognosis and therapy.Discovery of (pro)renin receptor [(P)RR] revealed that (P)RR upon binding to both renin or prorenin in their proenzyme inactive form made them enzymatically active, thus aiding the catalytic conversion of angiotensinogen (AGT) to angiotensin (Ang) I. This binding also transdu Read More
-
-
-
Pigment Epithelium-derived Factor (PEDF) and Cardiometabolic Disorders
Authors: Sho-ichi Yamagishi and Takanori MatsuiThe metabolic syndrome is strongly associated with insulin resistance and visceral obesity and consists of a constellation of factors such as diabetes, hypertension, dyslipidemia and non-alcoholic steatohepatits, which could in concert increase the risk for cardiovascular diseases (CVD). CVD, including myocardial infarction and stroke, is one of the leading causes of morbidity and mortality in the developed countries. Athe Read More
-
-
-
Dipeptidyl-peptidase 4 Inhibition: Linking Metabolic Control to Cardiovascular Protection
Authors: Angelo Avogaro, Saula de Kreutzenberg and Gianpaolo FadiniDipeptidyl peptidases 4 (DPP4) inhibitors are a new class of oral anti-hyperglycemic drugs for the treatment of type 2 diabetes (T2DM). They are also called “incretins” because they act by inhibiting the degradation of endogenous incretin hormones, in particular GLP-1, that mediates their main metabolic effects. DPP4 is an ubiquitous protease that regulates not only glucose and lipid metabolism, but also exhibits several sy Read More
-
-
-
Role of AGEs-RAGE System in Cardiovascular Disease
Authors: Kei Fukami, Sho-ichi Yamagishi and Seiya OkudaAdvanced glycation end products (AGEs) are a heterogenous group of molecules formed during a non-enzymatic reaction between proteins and sugar residues. Recently, AGEs and their receptor (receptor for AGEs; RAGE) play a central role in the pathogenesis of cardiovascular disease (CVD), which accounts for disability and high mortality rate in patients with diabetes. AGEs initiate diabetic micro- and macrovascular co Read More
-
-
-
Nonalcoholic Fatty Liver Disease and Cardiovascular Disease
Authors: Hideyuki Hyogo, Kazuaki Chayama and Sho-ichi YamagishiNonalcoholic fatty liver disease (NAFLD) is among the most common causes of chronic liver disease in the westernized world and now represents a worldwide public health problem. NAFLD encompasses a broad spectrum of conditions, ranging from simple steatosis (nonalcoholic fatty liver) to nonalcoholic steatohepatitis (NASH). The latter is recognized as a potentially progressive disease that could lead to cirrhosis, liver failure Read More
-
-
-
Mesenchymal Stromal Cell Therapy for Cardio Renal Disorders
Chronic kidney disease carries a very high mortality risk, in particular from cardiac diseases. Often heart failure and renal failure coincide, a phenomenon referred to as the cardio renal syndrome. In recent years, it has become clear that not only fibrotic repair but also restoration of damaged kidney and heart can occur and the use of cell therapy has been advanced as a means to activate endogenous repair mechan Read More
-
-
-
Novel Insights into Vascular Repair Mechanisms
Authors: Nicolle Krankel, Thomas F. Luscher and Ulf LandmesserEndothelial cell injury is considered to play a critical role for development and progression of atherosclerosis as well as for complications after percutaneous coronary artery interventions in patients with coronary disease. Through the course of human life, the endothelium is constantly replaced and exposure to endothelial cell damaging stimuli, such as cardiovascular risk factors, requires a substantially faster repair and Read More
-
-
-
Molecular Imaging of Vascular Inflammation
Atherosclerosis and its thrombotic complications represent the major cause of morbidity and mortality in the industrialized countries. Despite recent advances in the diagnosis and management of cardiovascular disease, a substantial number of patients still die from acute coronary syndromes. Recently, atherosclerotic plaque composition rather than the degree of arterial stenosis has been shown to reflect the plaqu Read More
-
Volumes & issues
-
Volume 31 (2025)
-
Volume 30 (2024)
-
Volume 29 (2023)
-
Volume 28 (2022)
-
Volume 27 (2021)
-
Volume 26 (2020)
-
Volume 25 (2019)
-
Volume 24 (2018)
-
Volume 23 (2017)
-
Volume 22 (2016)
-
Volume 21 (2015)
-
Volume 20 (2014)
- Issue 42
- Issue 41
- Issue 40
- Issue 39
- Issue 38
- Issue 37
- Issue 36
- Issue 35
- Issue 34
- Issue 33
- Issue 32
- Issue 31
- Issue 30
- Issue 29
- Issue 28
- Issue 27
- Issue 26
- Issue 25
- Issue 18
- Issue 24
- Issue 23
- Issue 22
- Issue 21
- Issue 20
- Issue 19
- Issue 17
- Issue 16
- Issue 15
- Issue 14
- Issue 13
- Issue 12
- Issue 11
- Issue 10
- Issue 9
- Issue 8
- Issue 7
- Issue 6
- Issue 5
- Issue 4
- Issue 3
- Issue 2
- Issue 1
-
Volume 19 (2013)
-
Volume 18 (2012)
-
Volume 17 (2011)
-
Volume 16 (2010)
-
Volume 15 (2009)
-
Volume 14 (2008)
-
Volume 13 (2007)
-
Volume 12 (2006)
-
Volume 11 (2005)
-
Volume 10 (2004)
-
Volume 9 (2003)
-
Volume 8 (2002)
-
Volume 7 (2001)
-
Volume 6 (2000)
Most Read This Month
Article
content/journals/cpd
Journal
10
5
false
en
